3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
14
Gynecologic
11
Sarcoma
9
Genitourinary
8
Breast
6
Head & Neck
5
Thoracic
4
Other solid neoplasm
3
Dermatologic
3
Tumor-Agnostic
1
Other hematologic neoplasm
1
Other
1
Conditions
Prehypertension
1
Prediabetic State
1
Polycystic Ovary Syndrome
1
Obesity
1
Metabolic Syndrome
1
Hyperthermia
1
Interventions
Exercise
27
Metformin
24
Methods
14
Radiotherapy
13
Early Intervention, Educational
13
Educational Status
12
Counseling
12
Surveys and Questionnaires
10
Standard of Care
10
Nutrition Assessment
9
Resistance Training
8
Diet Therapy
8
Cisplatin
8
naloxegol
7
Tirzepatide
7
Diet
7
alvimopan
6
Psychiatric Rehabilitation
6
Fibroblast Growth Factor 7
6
Caloric Restriction
6
Radiation
5
Low-Level Light Therapy
5
Liraglutide
5
Injections
5
Exenatide
5
Dexamethasone
5
Cryotherapy
5
semaglutide
4
angiotensin I (1-7)
4
Vitamin D
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Diathermy
×
Other
×
Clear all
NCT03644524
2018-08-23
CMH
University of Oregon
Phase NA
Completed
20 enrolled